Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBM for Diabetic Macular Edema
NCT02457975Phase 1Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2015
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in diabetic macular edema (DME), sponsored by Medical College of Wisconsin. Primary endpoint: Best Corrected Visual Acuity at 24 weeks. Started Jun 2015; status: completed.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02457975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457975.